form10k.htm

SECOND AMENDED AND RESTATED

CHANGE IN CONTROL AGREEMENT

This Second Amended and Restated Change in Control Agreement (the “Agreement”) is made as of January 11, 2010, by and between Universal Display Corporation (the “Company”), and Michael G. Hack (“Employee”).

WHEREAS, Employee is employed by UDC, Inc., an affiliate of the Company, currently serving in a capacity as Vice President, Strategic Product Development of the Company; and

WHEREAS, the Company believes that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of Employee to the Company without distraction notwithstanding the fact that the Company could be subject to a “Change in Control” (as hereinafter defined), and that such possibility, and the uncertainty and questions which it may raise among management, may result in the departure or distraction of key management personnel to the detriment of the Company;

WHEREAS, in consideration for Employee agreeing to continue in employment with the Company and its affiliate and agreeing to keep Company information confidential and not to compete with the Company (as hereinafter defined), the Company agrees that Employee shall receive the compensation set forth in this Agreement as a cushion against the financial and career impact on Employee in the event Employee’s employment with the Company is involuntarily terminated in connection with a Change in Control;

WHEREAS, the parties previously entered into an Amended and Restated Change in Control Agreement dated November 4, 2008, which agreement was intended to ensure conformity with the provisions of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder (the “Code”); and

WHEREAS, based on a change in the Employee’s employment status with the Company effective as of January 1, 2010, the parties are entering into this Second Amended and Restated Change in Control Agreement to ensure that the benefits afforded to Employee in connection with a Change in Control are commensurate with his new status with the Company.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements hereinafter set forth and intending to be legally bound hereby, the Company and Employee (individually a “Party” and together, the “Parties”) agree as follows:

1. Definitions.

(a) “Annual Base Salary” shall mean twelve (12) times the greater of: (a) the highest monthly base salary paid or payable (including any base salary which has been earned but deferred and any car allowance) to Employee by the Company and its affiliates (as defined in Section 1504 of the Code without regard to subsection (b) thereof), together with any and all salary reduction authorized amounts under any of the Company’s and its affiliates’ benefit plans or programs, during the twenty-four (24) month period immediately preceding the date of the Change in Control, or (b) the monthly base salary paid or payable to Employee by the Company

-1-

(b) and its affiliates (including authorized deferrals, salary reduction amounts and any car allowance), together with any and all salary reduction authorized amounts under any of the Company’s and its affiliates’ benefit plans or programs, for the last full month immediately prior to Employee’s Termination of Employment.

(c) “Annual Bonus” shall mean an amount equal to Employee’s highest annual bonus for the last three (3) full fiscal years prior to the Change in Control (annualized in the event that Employee was not employed for the whole of such fiscal year). If any such amount was paid in whole or in part in the form of stock options, stock appreciation rights, warrants, stock awards or performance units, whether or not restricted or subject to the satisfaction of any performance goals or other criteria, the annual bonus for such fiscal year shall include the fair market dollar value equivalent of all such stock options, stock appreciation rights, warrants, stock awards and performance units, determined as of the date of grant.

(d) “Board” shall mean the board of directors of the Company.

(e) “Cause” shall mean (i) conviction of a crime involving moral turpitude, or (ii) gross negligence in the performance of duties, which gross negligence is willful, has or has the potential to have a material adverse effect on the business, operations, assets, properties or financial condition of the Company and its affiliates taken as a whole, and is not cured within sixty (60) days after reasonable written notice from the Company.

(f) “Change in Control” shall mean the occurrence of any of the following:

(i) if any Person or affiliated group of Persons (other than in their capacities as trustees of a trust existing on the Effective Date or any successor trust having the same beneficiaries) first become the “beneficial owners” (as defined in Rule 13d-3 under the Securities Exchange Act), directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such Persons any securities acquired directly from the Company or its affiliates) representing thirty percent (30%) or more of either the then-outstanding shares of stock of the Company or the combined voting power of the Company’s then-outstanding securities;

(ii) if, during any period of twenty-four (24) consecutive months during the existence of this Agreement commencing on or after the date hereof, the individuals who, at the beginning of such period, constitute the Board (the “Incumbent Directors”) cease for any reason other than death to constitute at least a majority thereof; provided that a director who was not a director at the beginning of such twenty-four (24) month period shall be deemed to have satisfied such twenty-four (24) month requirement (and be an Incumbent Director) if such director was elected by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually (because they were directors at the beginning of such twenty-four (24) month period) or by prior operation of this clause (ii);

-2-

(iii) the consummation of a merger or consolidation of the Company with any other corporation other than (A) a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving of the Company or such surviving entity or any parent thereof) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity or any parent outstanding immediately after such merger or consolidation, or (B) a merger or consolidation effected to implement a recapitalization of the Company (or a similar transaction) in which no Person or group of affiliated Persons (other than in their capacities as trustees of a trust existing on the Effective Date or any successor trust having the same beneficiaries) first become the “beneficial owners” (as defined in Rule 13d-3 under the Securities Exchange Act), directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such Persons any securities acquired directly from the Company or its affiliates) representing thirty percent (30%) or more of either the then-outstanding shares of stock of the Company or the combined voting power of the Company’s then-outstanding securities;

(iv) the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company, or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than a sale or disposition by the Company of all or substantially all of the Company’s assets to an entity, at least fifty percent (50%) of the combined voting power of the voting securities of which are owned by Persons in substantially the same proportion as their ownership of the Company immediately prior to such sale; or

(v) any Person has consummated a tender offer or exchange for voting stock of the Company and, directly or indirectly, has become (in one or more transactions) the “beneficial owner” of securities of the Company representing a majority of the voting power of the then outstanding shares of stock of the Company.

Upon the occurrence of a Change in Control as provided above, no subsequent event or condition shall constitute a Change in Control for purposes of this Agreement, with the result that there can be no more than one Change in Control hereunder.

(g) “Code” shall mean the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.

(h) “Cure Period” shall mean the thirty (30) day period after the Company receives Employee’s Notice of Termination as described in Section 2 below, during which period the Company shall have the opportunity, if the act or omission is capable of correction, to correct the action or failure to act that constitutes the applicable occurrence as set forth in the Notice of Termination.

-3-

(i) “Effective Termination Date” shall mean:

(i) in the case of a Termination of Employment initiated by the Company at the time of or within two (2) years after a Change in Control, the date of Employee’s receipt of the Notice of Termination described in Section 2 hereof, or any later date specified therein on which a Termination of Employment is to occur (which date shall not be more than fifteen (15) days after the giving of such notice), as the case may be;

(ii) in the case of a Termination of Employment initiated by Employee at the time of or within two (2) years after a Change in Control, the date immediately following the end of the Cure Period for the action or failure to act that constitutes the applicable occurrence as set forth in the Employee’s Notice of Termination, provided that the Company shall not have, prior to such date, corrected such action or failure to act or Employee has not waived such failure; and

(iii) in the case of a Termination of Employment initiated by either the Company or Employee during the one (1) year period immediately preceding a Change in Control, the date of the Change in Control or, if sooner, the date the Company or its affiliates publicly announce an intention to consummate the Change in Control.

(j) “Person” shall mean any corporation, partnership, limited liability company, joint venture, other entity or natural person.

(k) “Separation Period” shall mean the twenty-four (24) month period beginning on the Effective Termination Date.

(l) “Termination of Employment” shall mean the termination of Employee’s active employment relationship with the Company or its affiliates.

(m) “Termination in Connection with a Change in Control” shall mean:

(i) Subject to the requirements of Section 2, a Termination of Employment at the time of or within two (2) years after a Change in Control either:

A. initiated by the Company or its affiliates for any reason other than (I) Employee’s death, continuous illness, injury or incapacity for a period of twelve (12) consecutive months, or (II) for Cause; or

B. initiated by Employee upon the occurrence of one or more of the following events without Employee’s consent, subject to any applicable Cure Period:

-4-

C. any material failure of the Company to comply with and satisfy any of the terms of this Agreement or any other material obligations of the Company or its affiliates to Employee;

(I) any significant reduction by the Company or its affiliates of the authority, duties, reporting responsibilities or job responsibilities of Employee;

(II) any removal by the Company or its affiliates of Employee from the employment grade, compensation level or officer positions which Employee holds as of the effective date hereof (except in connection with a promotion to higher office);

(III) the relocation of the offices of the Company at which Employee is principally employed to a location more than fifty (50) miles from such location immediately prior to the date that is six (6) months before the Change in Control, except for required travel on the Company’s business to any extent substantially consistent with Employee’s business travel obligations as of the date of this Agreement;

(ii) a Termination of Employment during the one (1) year period immediately preceding a Change in Control, which termination is initiated by the Company, or by Employee upon the occurrence of one or more of the events in clauses (I) – (IV) of subsection (l)(i)(B) above and without Employee’s consent, unless the Company establishes by clear and convincing evidence that such Termination of Employment was for good faith business reasons not related to the Change in Control.

2. Notice of Termination of Employment.

(a) The party initiating a Termination of Employment, whether Employee or the Company, shall communicate the Termination of Employment to the other party by a written notice of termination given in accordance with Section 16 hereof (a “Notice of Termination”). The Notice of Termination shall (i) briefly summarize the facts and circumstances deemed to provide a basis for the Termination of Employment; (ii) indicate, to the extent known, whether the party initiating termination considers the Termination of Employment to be a Termination in Connection with a Change in Control and, if so, the specific reasons why; (iii) if the Effective Termination Date is other than the date of receipt of such notice, specify the Effective Termination Date to the extent determinable, subject to any applicable Cure Period.

(b) If termination is initiated by Employee based on an event described in Section 1(l)(i)(B)(III)-(IV) above, such Notice of Termination shall be delivered to the Company within a reasonable period of time after the date on which Employee first has actual knowledge of the facts or circumstances giving rise thereto, such period not to exceed ninety (90) days following such date.

-5-

(c) To the extent the Termination of Employment is initiated during the one (1) year period immediately preceding a Change in Control, it is understood that whether the Termination of Employment is a Termination in Connection with a Change in Control may be unknown and the Effective Termination Date may be undeterminable at the time the Notice of Termination is delivered. In such event, the party initiating the Termination of Employment shall provide a supplemental written notice to the other party providing the additional information that was unknown or undeterminable at the time the original Notice of Termination was delivered (a “Supplemental Notice”). This Supplemental Notice shall be delivered within a reasonable period of time after the first date on which the initiating party learns of the Change in Control or, if sooner, the date of the publicly announced intention of the Company or its affiliates to consummate the Change in Control, such period not to exceed ninety (90) days after the earlier of the two dates.

3. Compensation upon Termination in Connection with a Change in Control. In the event of a Termination in Connection with a Change in Control, the Company shall pay to Employee, or provide to Employee at no additional cost for the length of the Separation Period, the following:

(a) An amount equal to Employee’s earned or accrued but unpaid compensation (including any unused paid time off) as of the date of Termination of Employment, said amount to be paid in a lump sum within fifteen (15) days after the Effective Termination Date, but in any event no later than March 15 of the year following the year of the Effective Termination Date.

(b) An amount equal to all reasonable out-of-pocket business expenses properly incurred but not yet reimbursed by the Company or its affiliates, said amount to be paid in a lump sum within fifteen (15) days after the Effective Termination Date, but in any event no later than March 15 of the year following the year of the Effective Termination Date.

(c) An amount equal to two (2) times the sum of the Annual Base Salary and the Annual Bonus, said amount to be paid in a lump sum within fifteen (15) days after the Effective Termination Date, but in any event no later than March 15 of the year following the year of the Effective Termination Date.

(d) An amount equal to the estimated after-tax premium cost to Employee of continuing any Company-sponsored life, travel and accident and disability insurance coverage for Employee (and where applicable, his or her spouse and dependents) based on the coverage levels in effect for Employee (and where applicable, his or her spouse and dependents) immediately prior to the Effective Termination Date (less any amount that Employee would have been required to contribute toward the cost of such coverage), for the length of the Separation Period, as if Employee had continued to be employed by the Company during the Separation Period at his or her Annual Base Salary, said amount to be paid in a lump sum within fifteen (15) days after the Effective Termination Date, but in any event no later than March 15 of the year following the year of the Effective Termination Date.

(e) An amount equal to the Company provided contributions to which Employee would be entitled under the Company’s or its affiliates’ 401(k) savings and retirement

-6-

(f) plans (whether qualified or non-qualified) (the “Benefit Plans”), if Employee had continued working for the Company during the Separation Period at his or her Annual Base Salary, and were making the maximum amount of employee contributions, if any, as are required under such Benefit Plans, said amount to be paid in a lump sum within fifteen (15) days after the Effective Termination Date, but in any event no later than March 15 of the year following the year of the Effective Termination Date.

(g) Effective immediately preceding the Change in Control (but contingent upon the consummation of the Change in Control), all outstanding equity awards held by Employee immediately preceding the Change in Control that have not yet become vested (and exercisable to the extent applicable) shall become fully vested (and exercisable to the extent applicable); provided that awards that vest based upon attainment of performance criteria shall not accelerate and vest pursuant to this Section 3(f) but shall instead be governed by the terms of the plan or award agreement evidencing the terms of such award.

(h) Continued group hospitalization, health and dental care coverage during the Separation Period, at the level in effect as of the Effective Termination Date (or generally comparable coverage) for Employee and, where applicable, Employee’s spouse and dependents, as the same may be changed by the Company from time to time for employees generally, as if Employee had continued in employment during the Separation Period. The COBRA healthcare continuation coverage period under Section 4980B of the Code shall run concurrently with the Separation Period.

(i) Outplacement assistance services during the Separation Period provided by an outplacement agency selected by Employee, said amount to be paid in a lump sum equal to $10,000 within fifteen (15) days after the Effective Termination Date, but in any event no later than March 15 of the year following the year of the Effective Termination Date.

Notwithstanding the foregoing, no such payments, benefits or services shall be made or provided (except as may be required by law) unless Employee executes, and does not revoke, a written release, substantially in the form attached hereto as ANNEX I (the “Release”), of any and all claims against the Company and all related parties with respect to all matters arising out of Employee’s employment by the Company or its affiliates (other than any entitlements under the terms of this Agreement or under any other plans or programs of the Company in which Employee participated and under which Employee has accrued or become entitled to a benefit), or the termination thereof.

4. Other Payments; Non-Exclusivity of Rights. The payments and benefits due under Section 3 hereof shall be in addition to and not in lieu of any payments or benefits due to Employee under any other plan, policy or program of the Company or its affiliates, including, without limitation, any employee benefit programs, compensation plans and programs, or other program permitting Employee to obtain benefits based on exceeding compensation limitations imposed by the Code, and any employee perquisite programs maintained for the benefit of the Company’s officers or employees, except that no cash payments shall be paid to Employee under the Company’s then-current severance pay policies. Moreover, nothing in this Agreement shall prevent or limit Employee’s continuing or future participation in or rights under any benefit,

-7-

5. bonus, incentive or other plan or program provided by the Company or its affiliates and for which Employee may qualify.

6. Enforcement.

(a) In the event that the Company shall fail or refuse to make payment of any amounts due Employee under Sections 3 and 4 hereof within the respective time periods provided therein, the Company shall pay to Employee, in addition to the payment of any other sums provided in this Agreement, interest, compounded daily, on any amount remaining unpaid from the date payment is required under Section 3 and 4, as appropriate, until paid to Employee, at the rate from time to time reported by The Wall Street Journal as its “prime rate” plus 2%, each change in such rate to take effect on the effective date of the change in such prime rate.

(b) It is the intent of the Parties that Employee not be required to incur any expenses associated with the enforcement of his or her rights under Sections 3 or 4 hereof by arbitration, litigation or other legal action because the cost and expense thereof would substantially detract from the benefits intended to be extended to Employee hereunder. Accordingly, the Company shall pay Employee, on demand, the amounts necessary to advance to, or reimburse Employee in full for, all expenses (including all attorneys’ fees and legal expenses) reasonably incurred by Employee in enforcing any of Employee’s rights under this Agreement.

7. No Mitigation. Employee shall not be required to mitigate the amount of any payment or benefit provided for in this Agreement by seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for herein be reduced by any compensation earned by other employment or otherwise.

8. No Set-Off. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim, recoupment, defense or other right which the Company or its affiliates may have against Employee or others.

9. Tax Withholding. Any payment required under this Agreement shall be subject to all requirements of the law with regard to the withholding of taxes, filing, making of reports and the like, and the Company shall use its best efforts to satisfy promptly all such requirements.

10. Tax Reimbursement Payments. In the event that any amount or benefit paid or distributed to Employee pursuant to this Agreement, taken together with any amounts or benefits otherwise paid or distributed to Employee by the Company or its affiliates (collectively, the “Covered Payments”), including, without limitation, any profits realized in respect of the receipt, vesting or exercise of stock options or warrants and similar events, are or become subject to the tax (the “Excise Tax”) imposed under Section 4999 of the Code, the Company shall pay to Employee at the time specified below an additional amount (the “Tax Reimbursement Payment”), such that the net amount retained by Employee with respect to such Covered Payments, after deducting any Excise Tax on the Covered Payments, as well as any Federal, state and local income taxes and Excise Tax on the Tax Reimbursement Payment provided for by this Section 9, but before deduction for any Federal, state or local income or employment tax

-8-

11. withholding on such Covered Payments, shall be equal to the amount of the Covered Payments. The Company shall reimburse Employee only as a result of excise taxes imposed under Section 4999 of the Code (or a successor Code provision of comparable intent).

(a) For purposes of determining whether any of the Covered Payments will be subject to the Excise Tax and the amount of such Excise Tax,

(i) such Covered Payments will be treated as “parachute payments” within the meaning of Section 280G of the Code, and all “parachute payments” in excess of the “base amount” (as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless, and except to the extent that, in the good faith judgment of the Company’s independent certified public accountants or tax counsel selected by such Accountants (the “Accountants”), such Covered Payments, in whole or in part, either do not constitute “parachute payments” or represent reasonable compensation for personal services actually rendered (within the meaning of Section 280G(b)(4)(B) of the Code) in excess of the “base amount,” or such “parachute payments” are otherwise not subject to the Excise Tax, and

(ii) the value of any non-cash benefits or any deferred payments or benefits shall be determined by the Accountants in accordance with the principles of Section 280G of the Code.

(b) For purposes of determining the amount of the Tax Reimbursement Payment, Employee shall be deemed to pay:

(i) Federal income taxes at the highest applicable marginal rate of Federal income taxation for the calendar year in which the Tax Reimbursement Payment is to be made, and taking into account the effect of loss of the value of itemized deductions and personal exemptions as a result of Employee’s receipt of the Tax Reimbursement Payment; and

(ii) any applicable state and local income taxes at the highest applicable marginal rate of taxation for the calendar year in which the Tax Reimbursement Payment is to be made, net of the maximum reduction in Federal incomes taxes that could be obtained from the deduction of such state or local taxes if paid in such year.

(c) In the event that the Excise Tax is subsequently determined by the Accountants, or pursuant to any proceeding or negotiations with the Internal Revenue Service, to be less than the amount taken into account hereunder in calculating the Tax Reimbursement Payment made, Employee shall repay to the Company, at the time that the amount of such reduction in the Excise Tax is finally determined, the portion of such prior Tax Reimbursement Payment that would not have been paid if such Excise Tax had been applied in initially calculating such Tax Reimbursement Payment, plus interest on the amount of such repayment at the rate provided in Section 1274(b)(2)(B) of the Code. Notwithstanding the foregoing, in the event any portion of the Tax Reimbursement Payment to be refunded to the Company has been

-9-

(d) paid to any Federal, state or local tax authority, repayment thereof shall not be required until actual refund or credit of such portion has been made to Employee, and interest payable to the Company shall not exceed interest received or credited to Employee by such tax authority for the period it held such portion. Employee and the Company shall mutually agree upon a course of action to be pursued (and the method of allocating the expenses thereof) if Employee’s good faith claim for refund or credit is denied.

(e) In the event that the Excise Tax is later determined by the Accountants, or pursuant to any proceeding or negotiations with the Internal Revenue Service, to exceed the amount taken into account hereunder at the time the Tax Reimbursement Payment is made (including, but not limited to, by reason of any payment the existence or amount of which cannot be determined at the time of the Tax Reimbursement Payment), the Company shall make an additional Tax Reimbursement Payment in respect of such excess (plus any interest or penalty payable with respect to such excess) at the time that the amount of such excess is finally determined.

(f) The Tax Reimbursement Payment (or any portion thereof) provided for in this Section 9 shall be paid to Employee not later than fifteen (15) days following payment of the Covered Payments; provided, however, that if the amount of such Tax Reimbursement Payment (or any portion thereof) cannot be finally determined on or before the date on which payment is due, the Company shall pay to Employee by such date an amount estimated in good faith by the Accountants to be the minimum amount of such Tax Reimbursement Payment, and shall pay to Employee the remainder of such Tax Reimbursement Payment (together with interest at the rate provided in Section 1274(b)(2)(B) of the Code) as soon as the amount thereof can be determined, but in no event later the end of Employee’s taxable year next following Employee’s taxable year in which Employee remits the taxes for which the Tax Reimbursement Payment is being paid. In the event that the amount of the estimated Tax Reimbursement Payment exceeds the amount subsequently determined to have been due, such excess shall be paid by the Company to Employee, within fifteen (15) days after written demand by the Company for repayment (together with interest at the rate provided in Section 1274(b)(2)(B) of the Code).

(g) Notwithstanding anything in this Agreement to the contrary, if applicable, the Company shall not pay Covered Payments and Tax Reimbursement Payments under this Agreement earlier than the earliest date permitted by Section 409A of the Code, or later than the latest date permitted by Section 409A of the Code, if, as determined in the reasonable judgment of outside counsel hired by the Company, payment on the originally scheduled date would cause the Employee to incur adverse tax consequences under Section 409A of the Code. Covered Payments and Tax Reimbursement Payments that are subject to Section 409A of the Code shall only be paid upon an event permitted by Section 409A of the Code, and this Agreement shall be administered consistently with Section 409A of the Code, to the extent applicable.

12. Section 409A of the Code.

(a) Amounts payable under this Agreement are intended, in whole or in part, to meet the requirements of the “short-term deferral” exception or another exception under Section 409A of the Code. For purposes of Section 409A of the Code, all payments to be made upon a termination of employment under this Agreement may only be made upon a “separation

-10-

(b) from service” within the meaning of such term under Section 409A of the Code and each payment made under this Agreement shall be treated as a separate payment. In no event shall the Employee, directly or indirectly, designate the calendar year of payment. All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during the Employee’s lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred, and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.

(c) Notwithstanding anything in this Agreement to the contrary, if at the time of the Employee’s “separation from service” with the Company, the Company has securities which are publicly-traded on an established securities market and the Employee is a “specified employee,” and it is necessary to postpone payment of any amount under this Agreement for a period of six (6) months after the Employee’s “separation from service” with the Company to prevent any accelerated or additional tax under Section 409A of the Code, payment of such amount shall be postponed as required by Section 409A of the Code, and the accumulated postponed amount, with interest (as described below), shall be paid in a lump sum payment within ten (10) days after the end of the six-month period. If the Employee dies during the postponement period prior to the payment of postponed amount, the amounts postponed on account of Section 409A of the Code, with interest, shall be paid to the personal representative of the Employee’s estate within sixty (60) days after the date of the Employee’s death. A “specified employee” shall mean an employee who, at any time during the twelve (12) month period ending on the identification date, is a “specified employee” under Section 409A of the Code, as may be determined by the Company’s Board of Directors or its delegate. The determination of “specified employees,” including the number and identity of persons considered “specified employees” and the identification date, shall be made by the Company’s Board of Directors or its delegate in accordance with the provisions of Sections 416(i) and 409A of the Code and the regulations issued thereunder. If amounts are postponed on account of Section 409A, the postponed amounts will be credited with interest for the postponement period. Said interest shall be compounded daily at an annualized rate equal to the interest rate reported by The Wall Street Journal as its “prime rate” on the Effective Termination Date.

13. Confidential Information. Employee recognizes and acknowledges that, by reason of his or her employment by and service to the Company, he or she has had and will continue to have access to confidential information of the Company, including, without limitation, information and know-how pertaining to the Company’s products and services, innovations, designs, ideas, plans, trade secrets, proprietary inventions, distribution and sales methods and systems, sales and profit figures, customer and supplier lists, and relationships with customers, suppliers and others (“Confidential Information”). Employee acknowledges that such Confidential Information is a valuable and unique asset of the Company and covenants that he or she will not, either during or after his or her employment by the Company, disclose or use any Confidential Information for any purpose known to be adverse to the interests of the Company,

-11-

14. unless the information is already in the public domain through no fault of Employee or such disclosure or use is required by law or in a judicial or administrative proceeding.

15. Non-Competition and Non-Solicitation.

(a) During Employee’s employment by the Company and for a period of six (6) months after Employee’s Termination in Connection with a Change in Control, Employee will not, except with the prior written consent of the Board (which consent shall not be unreasonably withheld or delayed), own, manage, operate, join, control or finance, or participate in the ownership, management, operation, control or financing of, or be connected as an officer, director, employee, partner, principal, agent, representative, consultant or otherwise with, or use or permit Employee’s name to be used in connection with, any business or enterprise directly engaged in, or with affiliates directly engaged in, the business of researching, developing, licensing, selling, distributing, marketing or otherwise commercializing organic light emitting device (“OLED”) technology, chemicals or manufacturing equipment. The foregoing restrictions shall not be construed to prohibit the ownership by Employee of less than five percent (5%) of any class of securities of a corporation engaged in any of the foregoing business activities that has a class of securities registered pursuant to the Securities Exchange Act, provided that such ownership represents a passive investment and that neither Employee nor any group of Persons including Employee, either directly or indirectly, manages or exercises control over any such corporation, guarantees any of its financial obligations, otherwise takes any part in the conduct of its business (other than in exercising their rights as shareholders), or seeks to do any of the foregoing.

(b) During his or her employment by the Company, and thereafter during the Separation Period, Employee will not knowingly (i) solicit, divert, take away, redirect or unreasonably interfere with the Company’s business relationships with any of its suppliers, customers, partners or joint venturers with whom Employee had any direct or indirect involvement during the term of this Agreement; or (ii) solicit, induce, recruit or attempt to influence any person who is now or is hereafter an employee of the Company to become an employee or be engaged as an independent contractor of any entity engaged in activities competitive with those of the Company.

(c) An amount equal to one-half of the severance benefits payable under this Agreement is specifically designated as additional consideration for the covenants described in this Section 12. The covenants described in this Section 12 shall continue to apply during the period specified herein after Employee’s Termination of Employment for any reason, without regard to whether Employee executes a Release or receives any severance benefits as a result of such termination. If Employee breaches any of the covenants described in this Section 12, the applicable period during which the covenant applies shall be tolled during the period of such breach.

16. Equitable Relief.

(a) Employee acknowledges that the restrictions contained in Sections 11 and 12 hereof are reasonable and necessary to protect the legitimate interests of the Company and its

-12-

(b) affiliates, that the Company would not have entered into this Agreement in the absence of such restrictions, and that any violation of any provision of those Sections will result in irreparable injury to the Company. Employee agrees that the Company shall be entitled to preliminary and permanent injunctive relief, without the necessity of proving actual damages, as well as an equitable accounting of all earnings, profits and other benefits arising from any violation of Sections 11 or 12 hereof, which rights shall be cumulative and in addition to any other rights or remedies to which the Company may be entitled. In the event that any of the provisions of Sections 11 or 12 hereof should ever be adjudicated to exceed the time, geographic, service, or other limitations permitted by applicable law in any jurisdiction, then such provisions shall be deemed reformed in such jurisdiction to the maximum time, geographic, service, or other limitations permitted by applicable law.

(c) Employee irrevocably and unconditionally (i) agrees that any suit, action or other legal proceeding arising out of Section 11 or 12 hereof, including without limitation, any action commenced by the Company for preliminary and permanent injunctive relief or other equitable relief, may be brought in the state or federal courts of the State of New Jersey, (ii) consents to the non-exclusive jurisdiction of any such court in any such suit, action or proceeding, and (iii) waives any objection which Employee may have to the laying of venue of any such suit, action or proceeding in any such court. Employee also irrevocably and unconditionally consents to the service of any process, pleadings, notices or other papers in a manner permitted by the notice provisions of Section 16 hereof.

17. Term of Agreement. This Agreement shall continue in full force and effect until all of the obligations of the Parties hereunder are satisfied or have expired.

18. Successor Company. The Company shall require any successor or successors (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company, by written agreement in form and substance reasonably satisfactory to Employee, to acknowledge expressly that this Agreement is binding upon and enforceable against the Company in accordance with the terms hereof, and to become jointly and severally obligated with the Company to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession or successions had taken place. Failure of the Company to obtain such agreement prior to the effectiveness of any such succession shall be a breach of this Agreement. As used in this Agreement, the Company shall mean the Company as hereinbefore defined and any such successor or successors to its business and/or assets, jointly and severally.

19. Notices. All notices and other communications required or permitted hereunder or necessary or convenient in connection herewith shall be in writing and shall be delivered personally or mailed by registered or certified mail, return receipt requested, or by overnight express courier service, as follows:

If to the Company, to:

	Universal Display Corporation 375 Phillips Boulevard Ewing, New Jersey 08618 Attention: President and Chief Executive Officer

If to Employee, to Employee’s address of record with the Company

-13-

or to such other names or addresses as the Company or Employee, as the case may be, shall designate by notice to the other in the manner specified in this Section 16; provided, however, that if no such notice is given by the Company following a Change in Control, notice at the last address of the Company or to any successor pursuant to this Section 16 shall be deemed sufficient for the purposes hereof. Any such notice shall be deemed delivered and effective when received in the case of personal delivery, five (5) days after deposit, postage prepaid, with the U.S. Postal Service in the case of registered or certified mail, or on the next business day in the case of overnight express courier service.

20. Governing Law. This Agreement shall be governed by and interpreted under the laws of the State of New Jersey, without giving effect to any conflict of laws provisions.

21. Contents of Agreement, Amendment and Assignment.

(a) This Agreement supersedes all prior agreements, sets forth the entire understanding between the Parties hereto with respect to the subject matter hereof and cannot be changed, modified, extended or terminated except upon written amendment executed by Employee and executed on the Company’s behalf by a senior executive officer or a senior management representative having supervisory responsibility with respect to Employee and/or Board approval. The provisions of this Agreement may provide for payments to Employee under certain compensation or bonus plans under circumstances where such plans would not provide for payment thereof. It is the specific intention of the Parties that the provisions of this Agreement shall supersede any provisions to the contrary in such plans, and such plans shall be deemed to have been amended to correspond with this Agreement without further action by the Company or the Board.

(b) Nothing in this Agreement shall be construed as giving Employee any right to be retained in the employ of the Company, or as changing or modifying the “at will” nature of Employee’s employment status.

(c) All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, representatives, successors and assigns of the Parties hereto, except that the duties and responsibilities of Employee and the Company hereunder shall not be assignable, in whole or in part, except as expressly authorized herein. If Employee should die after a Termination in Connection with a Change in Control and while any amount payable hereunder would still be payable to Employee if Employee had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance

(d) with the terms of this Agreement to Employee’s devises, legates or other designees or, if there is no such designee, to Employee’s estate.

(e) Notwithstanding the foregoing, the Company may amend this Agreement at any time without the consent of the Employee if the Company determines, based on the advice of outside counsel, that such amendment is necessary to comply with the requirements of Section 409A of the Code with respect to any particular amount or benefit that the Employee is entitled to receive under this Agreement. However, no amendment shall reduce the aggregate amounts and benefits the Employee is entitled to receive hereunder unless such aggregate amounts and benefits are prohibited by Section 409A of the Code or other applicable law.

-14-

22. Severability; Effect of Legal Restrictions. If any provision of this Agreement or application thereof to anyone or under any circumstances shall be determined to be invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions or applications of this Agreement which can be given effect without the invalid or unenforceable provision or application. Moreover, the terms of this Agreement shall be deemed modified to the extent necessary for the Company, in the written opinion of its outside counsel, to avoid violating the requirements of the Sarbanes-Oxley Act of 2002, or any other law applicable to the employment arrangements between Employee and the Company. Any delay in providing benefits or payments, any failure to provide a benefit or payment, or any repayment of compensation that is required due to operation of the preceding sentence shall not, in and of itself, constitute a breach of this Agreement; provided, however, that the Company shall provide economically equivalent payments or benefits to Employee to the extent permitted by law.

23. Remedies Cumulative; No Waiver. Except as otherwise expressly set forth herein, no right conferred upon either Party by this Agreement is intended to be exclusive of any other right or remedy, and each and every such right or remedy shall be cumulative and shall be in addition to any other right or remedy given hereunder, or now or hereafter existing at law or in equity. No delay or omission by either Party in exercising any right, remedy or power hereunder or existing at law or in equity shall be construed as a waiver thereof.

24. Miscellaneous. All section headings are for convenience only. This Agreement may be executed in several counterparts, each of which is an original. It shall not be necessary in making proof of this Agreement or any counterpart hereof to produce or account for any of the other counterparts.

-15-

EMPLOYEE REPRESENTS AND ACKNOWLEDGES THAT (I) HE OR SHE HAS BEEN ADVISED BY THE COMPANY TO CONSULT HIS OR HER OWN LEGAL COUNSEL IN RESPECT OF THIS AGREEMENT, AND (II) THAT HE OR SHE HAS HAD FULL OPPORTUNITY, PRIOR TO EXECUTION OF THIS AGREEMENT, TO REVIEW THOROUGHLY THIS AGREEMENT WITH HIS OR HER COUNSEL.

IN WITNESS WHEREOF, the undersigned, intending to be legally bound, have executed this Agreement as of the date first above written.

	UNIVERSAL DISPLAY CORPORATION
	By:	/s/ Sidney D. Rosenblatt
	Name:	Sidney D. Rosenblatt
	Title:	CFO
/s/ Scott Bovino		/s/ Michael Hack
Witness		EMPLOYEE

-16-

ANNEX I

SEPARATION OF EMPLOYMENT AGREEMENT AND GENERAL RELEASE

WHEREAS Michael G. Hack (“Employee”) has been employed by Universal Display Corporation (the “Company”) and its affiliate, UDC, Inc., and because the Employee’s employment with the Company terminated or will terminate effective as of ____________________ (the “Effective Termination Date”), Employee and the Company agree as follows:

In consideration of the promises of the Company set forth in paragraph 3 below, Employee, and his or her heirs, executors and administrators, intending to be legally bound, hereby permanently and irrevocably agrees to the termination of Employee’s employment with the Company as of the Effective Termination Date, and hereby REMISE, RELEASE and FOREVER DISCHARGE the Company and any individual or organization related to the Company against whom or which Employee could assert a claim, including any and all affiliates, and their officers, directors, shareholders, partners, employees and agents, together with their respective successors and assigns, heirs, executors and administrators (hereinafter referred to collectively as the “Releasees”), of and from any and all causes of action, suits, debts, claims and demands whatsoever, which Employee had, has, or may have against Releasees up until the date of execution of this Separation of Employment Agreement and General Release, other than the Release Exclusions (as defined below). Particularly, but without limitation, Employee so releases all claims relating in any way to his employment or the termination of his employment relationship with the Company, including without limitation claims under the New Jersey Law Against Discrimination, N.J.S.A. 10:5-1 et al., Title VII of the Civil Rights Act of 1964, as amended, § 42 U.S.C. 2000e et seq., the Americans with Disabilities Act, 42 U.S.C. § 12101 et seq., Employee Retirement Income Security Act of 1974, as amended 29 U.S.C. § 1001 et seq., the Age Discrimination in Employment Act, as amended 29 U.S.C. § 621 et seq. (the “ADEA”), any common law claims and all claims for attorneys’ fees and costs.

Employee agrees and covenants that, should any other person, organization or other entity file, charge, claim, sue, or cause or permit to be filed any civil action, suit or legal proceeding involving any matter occurring at any time in the past, up to and including the date of execution of this Separation of Employment Agreement and General Release, Employee will not seek or accept any personal relief in such civil action, suit or legal proceeding. Moreover, Employee shall promptly take all steps necessary to dismiss, with prejudice, any and all pending complaints, charges and grievances against the Company or the Releasees, regardless of whether they are or have been filed internally or externally.

Notwithstanding anything to the contrary in this Separation of Employment Agreement and General Release, nothing herein relinquishes any rights Employee may have to the following claims, or to any civil actions, suits or legal proceedings involving such claims (the “Release Exclusions”): (i) claims to seek indemnification pursuant to applicable state law, the Company’s By-Laws, applicable Company resolutions, applicable Company employee benefit plans or other such documents maintained or required to be maintained by the Company, (ii) claims to seek coverage under directors’ and officers’ liability insurance policies maintained or required to be

-17-

maintained by the Company, and (iii) claims to seek enforcement of Employee’s rights under the Change in Control Agreement between Employee and the Company (the “Change in Control Agreement”).

In full consideration of Employee’s execution of this Separation of Employment Agreement and General Release, and his or her agreement to be legally bound by its terms, the Company has agreed to provide Employee with the payments, benefits and other consideration specified in the Change in Control Agreement. Except as set forth in this Separation of Employment Agreement and General Release, or as may be required by applicable law, it is expressly agreed and understood that Releasees do not have, and will not have, any obligation to provide Employee, at any time in the future, with any payments, benefits or other consideration not specified in the Change in Control Agreement.

Employee hereby agrees and recognizes that, as of the Effective Termination Date, Employee’s employment relationship with the Company will be permanently and irrevocably severed. Accordingly, Employee will not apply for a position with the Company or any of its affiliates and Employee waives his or her right to be hired or rehired in the future by the Company or any of its affiliates. It is further agreed and understood that Employee will continue to be available and cooperate in a reasonable manner in providing assistance to the Company in concluding any matters which are reasonably related to the duties and responsibilities which Employee had while employed by the Company, provided that such cooperation and assistance does not interfere with any subsequent employment obtained by Employee.

Employee agrees and acknowledges that this Separation of Employment Agreement and General Release is not and shall not be construed to be an admission of any violation by the Releasees of any federal, state or local statute or regulation, or of any duty owed by the Releasees to Employee or any other person.

Employee agrees, covenants and promises that Employee will not communicate or disclose the terms of this Separation of Employment Agreement and General Release to any persons with the exception of members of Employee’s immediate family and Employee’s attorneys and financial advisors, except as may be required by applicable law.

Employee hereby certifies that Employee has read the terms of this Separation of Employment Agreement and General Release, that Employee has been advised by the Company to consult with an attorney of his or her own choice prior to executing this Separation of Employment Agreement and General Release, that Employee has had an opportunity to do so, and that Employee understands the terms and effects of this Separation of Employment Agreement and General Release. Employee further certifies that neither the Releasees, nor any representative of Releasees, have made any representations to Employee concerning this Separation of Employment Agreement and General Release other than those contained herein.

Employee acknowledges that Employee has been informed that this Separation of Employment Agreement and General Release includes a waiver of claims under the ADEA, and that Employee has the right to reconsider this Separation of Employment Agreement and General Release as it pertains to claims under the ADEA for a period of twenty-one (21) days (or forty-five (45) days in the event of a group termination). Employee also understands that he or she has

-18-

the right to revoke this Separation of Employment Agreement and General Release in its entirety for a period of seven (7) days following Employee’s execution thereof. Should Employee desire to exercise any of the foregoing rights, Employee shall do so by providing written notice to the Company within the applicable period at the following address: Universal Display Corporation at 375 Phillips Boulevard, Ewing, New Jersey 08618, Attention: President.

This Separation of Employment Agreement and General Release, together with the Change in Control Agreement, constitute the complete and entire understanding between the parties relating to the subject matter of such documents, and supersede any and all prior agreements and understandings between the parties relating thereto. If any provision of this Separation of Employment Agreement and General Release is deemed invalid, the remaining provisions shall not be affected. The provisions of this Separation of Employment Agreement and General Release shall be governed by the laws of New Jersey, without giving effect to any conflict of laws provisions.

IN WITNESS WHEREOF, and intending to be legally bound hereby, Employee has executed this Separation of Employment Agreement and General Release as of the date indicated below.


EMPLOYEE		Date

Acknowledgment of Receipt by:		UNIVERSAL DISPLAY CORPORATION

		By:
		Name:
		Title:

-19-

OLED TECHNOLOGY LICENSE AGREEMENT

THIS OLED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is entered into effective as of November 30, 2009 (the “Effective Date”), by and between Universal Display Corporation, a Pennsylvania corporation with a place of business at 375 Phillips Blvd, Ewing, New Jersey 08618, U.S.A. (“Universal Display”); and Showa Denko K.K. (“Showa Denko”), a Japanese corporation with a place of business at 13-9, Shiba Daimon 1-chome, Minat o-ku, Tokyo, 105-8518 Japan.

BACKGROUND

WHEREAS, Universal Display has rights in certain patents and possesses certain know-how concerning Organic Light Emitting Devices; and

WHEREAS, Showa Denko desires to obtain license rights to practice under these patents and to use this know-how on the terms and conditions set forth herein.

NOW, THEREFORE, intending to be legally bound, each of Showa Denko and Universal Display hereby agrees as follows:

AGREEMENT

Article 1 Definitions

In addition to other terms defined elsewhere herein, the following terms shall have their corresponding meanings when used in this Agreement.

1.1 “Affiliate” means all entities under the control of a party, whether directly or through one or more intermediaries. For such purposes, “control” shall mean the ability to make, or participate meaningfully in the making of, business decisions on behalf of the relevant entity. [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

1.2 “Know-How” means unpatented technical information, data, specifications, plans, drawings, designs, blueprints, formulae, processes and other similar items of a trade secret or confidential nature.

1.3 “Licensed Product” means an OLED Light Source, or any product or part thereof that incorporates one or more OLED Light Sources, which OLED Light Source(s) (a) are covered, in whole or in part, by any Valid Claim(s) of a Universal Display Patent; (b) are manufactured using a process that is covered, in whole or in part, by any Valid Claim of a Universal Display Patent; and/or (c) are manufactured using any of the Universal Display Know-How.

1.4 “Lighting” means a source of direct or indirect illumination, including, but not limited to, a room, area or architectural lighting source, a backlight for an LCD display or other

Universal Display Corporation

Page 1 of 19

1.5 consumer electronics product, or a source of illumination for signage; provided, however, that the source of illumination shall not itself utilize addressable pixel elements.

1.6 “Net Sales Revenue”

1.6.1 For Licensed Products that are sold by Showa Denko or Permitted Sublicensees to non-Affiliated third parties solely for cash, “Net Sales Revenue” means the gross amount invoiced or received, whichever occurs sooner, on account thereof, less the following items where separately itemized on the customer invoice for the Licensed Products: (a) discounts and allowances not otherwise credited to the customer or its Affiliates; (b) taxes and duties actually remitted to the appropriate taxing authorities and not refunded; (c) transportation charges actually paid to third-party carriers; (d) insurance costs actually paid or accrued for such purpose; and (e) refunds or credits actually given for returned or defective items.

1.6.2 For all other Licensed Products sold or otherwise transferred by Showa Denko or Permitted Sublicensees, “Net Sales Revenue” means the greater of (a) or (b), where (a) is the transfer price recorded by Showa Denko or the Permitted Sublicensee for such sale or transfer; and (b) is the average amount of Net Sales Revenue according to Section 1.5.1 above at which Licensed Products of similar kind and quantity have been sold by Showa Denko or the Permitted Sublicensee to non-Affiliated third parties during the same calendar quarter, or if no such amount is available, the fair market value of such Licensed Products.

1.6.3 If either party presents reasonable evidence that the amount calculated as set forth above does not fairly reflect the fair market value of any Licensed Product (such as evidence that the industry-wide average sales price of substantially similar products differs significantly from the price calculated herein, or evidence that additional consideration is being received by Showa Denko or the Permitted Sublicensee based on the downstream sale of a Licensed Product), the parties shall in good faith negotiate a more equitable method of calculating Net Sales Revenue with respect to such Licensed Products.

1.7 “OLED” or “Organic Light Emitting Device” means a device consisting of two electrodes, together with one or more chemical substances deposited between these two electrodes, at least one of which is an organic or organometallic material, which device emits light when a voltage is applied across the electrodes, and the like device.

1.8 “OLED Light Source” means an OLED device fabricated by a Solution Processing Method, or a series of such devices, which OLED device(s) are intended for use in Lighting applications, including [The confidential material contained herein has been omitted and has been separately filed with the Commission.] Two potential configurations of an OLED Light Source, by example only, are set forth in Exhibit A attached hereto.

1.9 “Permitted Sublicensee” means any corporation or other legal entity more than [The confidential material contained herein has been omitted and has been separately filed with the Commission.] of whose outstanding shares (representing the right to vote for the election of the majority of directors or other managing authority) are now, or hereinafter owned and controlled directly or indirectly by Showa Denko, but such corporation, company or other legal

Universal Display Corporation

Page 2 of 19

1.10 entity (a) shall be deemed a Permitted Sublicensee only so long as such ownership and control exists; and (b) shall not include any joint venture or other similar entity formed with a third party having its own OLED development program or OLED business.

1.11 “Solution Processing Method” means a fabrication method wherein [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

1.12 “Universal Display Know-How” means Know-How of Universal Display relating to the design or manufacture of an OLED Light Source.

1.13 “Universal Display Patents” means all patents and patent applications pertaining to OLED Light Sources that are issued, registered, granted, allowed or published in the world as of the Effective Date and which Universal Display owns or has the right to license to Showa Denko hereunder, including, but not limited to, the issued, registered, granted or published patents and patent applications listed in Exhibit C, together with such future patents and patent applications as are specified in Section 2.3 below.

1.14 “Universal Display Technology” means the Universal Display Patents and the Universal Display Know-How.

1.15 “Valid Claim” means a claim of an issued, registered, granted, allowed or published patent or patent application, which claim has neither expired nor been finally held unpatentable, invalid or unenforceable by a court or other government agency of competent jurisdiction.

Article 2 License Rights

2.1 Grant of License to Showa Denko. Subject to the remaining provisions of this Article 2, Universal Display hereby grants to Showa Denko a worldwide, royalty-bearing, non-exclusive and non-transferable (except in connection with a permitted transfer of this Agreement as a whole) license right, without rights to sublicense except as permitted in Section 2.2 below, under the Universal Display Patents, and to use the Universal Display Know-How, to manufacture, have manufactured (but only in accordance with the following sentence), sell, offer for sale and use Licensed Products. [The confidential material contained herein has been omitted and has been separately filed with the Commission.]< /font>

2.2 Permitted Sublicensees. Showa Denko shall be permitted to grant sublicenses of the foregoing license rights solely to its Permitted Sublicensees, provided that (a) each such sublicense shall be pursuant to a written agreement between Showa Denko and the Permitted Sublicensee, which written agreement shall obligate the Permitted Sublicensee to abide by the scope of license and other applicable provisions of this Agreement; (b) in addition to its other rights or remedies hereunder, Universal Display shall be expressly identified in the written sublicense agreement as a third-party beneficiary thereof, entitled to enforce the scope of license and other applicable provisions of this Agreement direct ly against the Permitted Sublicensee; (c) Showa Denko shall identify the name and business address of each such Permitted Sublicensee to

Universal Display Corporation

Page 3 of 19

2.3 Universal Display in writing promptly following its entry into a written sublicense agreement with the Permitted Sublicensee; and (d) Showa Denko shall use its best efforts to cause each Permitted Sublicensee abide by the scope of license and other applicable provisions of this Agreement.

2.4 License Rights to Future Patents and Know-How. To the extent it has the right to do so, Universal Display shall expand Showa Denko’s license rights under Section 2.1 above to include any additional patents, patent applications and Know-How of Universal Display pertaining to OLED Light Sources that are owned by or licensed to Universal Display and which are issued, registered, granted, allowed published or generated during the first five (5) years of the Term (defined below) [The confidential material contained herein has been omitted and has been separately filed with the Commission.] Universal Display shall periodically (at least two times per year) update Exhibit C to include any such additional patents and patent applications that are issued, registered, granted, allowed or published, and promptly notify the updated Exhibit C to Showa Denko.

2.5 No Rights Respecting Certain OLED Chemicals. [The confidential material contained herein has been omitted and has been separately filed with the Commission.] As used herein, “Universal Display Proprietary OLED Chemical” means [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

2.6 No Rights Respecting Certain OLED Manufacturing Equipment. Nothing in this Agreement shall be construed as authorizing or otherwise permitting Showa Denko, any Permitted Sublicensee or Authorized Contract Manufacturer, or any third party claiming through them, to practice under any Universal Display Patents, or to use any Universal Display Know-How, for purposes of manufacturing equipment or machinery used to produce an OLED [The confidential material contained herein has been omitted and has been separately filed with the Commission.] (“Universal Display Proprietary OLED Manufacturing Equipment”). Showa Denk o and its Permitted Sublicensees and Authorized Contract Manufacturers shall not manufacture Licensed Products hereunder using any Universal Display Proprietary OLED Manufacturing Equipment that they know, or have reason to know, is being made for or sold to them without appropriate license rights having been obtained from Universal Display.

2.7 Acknowledgement of Derivative Rights. Showa Denko acknowledges that certain of the Universal Display Technology is licensed by Universal Display from the Trustees of Princeton University (“Princeton”), the University of Southern California (“USC”), the University of Michigan (“Michigan”) and Motorola, Inc. (“Motorola”), and, therefore, that Showa Denko’s license rights under this Agreeme nt with respect to such Universal Display Technology are subject to the reserved rights of and obligations to such third parties under their license agreements with Universal Display. Showa Denko further acknowledges that the U.S. Government has certain reserved rights with respect to those Universal Display Patents claiming inventions that were first conceived or reduced to practice under contracts between the U.S. Government and Universal Display or its licensors. Universal Display hereby covenants to Showa Denko that: (a) Universal Display shall comply in all material respects with the terms of its license agreements with such third-party licensors and its contracts with or awards from the U.S. Government as in either case are relevant to Showa Denko’s exercise of the license rights

Universal Display Corporation

Page 4 of 19

2.8 granted by Universal Display hereunder; and (b) no additional consideration shall be owed by Showa Denko to such third-party licensors or the U.S. Government on account of Showa Denko’s exercise of such license rights. Nothing herein shall be construed as limiting or restricting the reserved rights of or obligations to Universal Display’s third-party licensors or the U.S. Government with respect to the Universal Display Technology. Upon Showa Denko’s request, Universal Display shall provide Showa Denko with copies (which may be reasonably redacted by Universal Display to avoid disclosing confidential information not relevant to this Agreement) of such of Universal Display’s agreements with such third-party licensors and of t he applicable portions its relevant contracts with or awards from the U.S. Government.

2.9 Business Consolidations. Should Showa Denko acquire the existing OLED business of any third party, or should a third party acquire the OLED business of Showa Denko, the license rights granted to Showa Denko under this Agreement shall not extend to any current products of such third party’s OLED business unless expressly agreed to by Universal Display in writing. [The confidential material contained herein has been omitted and has been separately filed with the Commission.] Should Universal Display have already entered into a similar license agreement with the third party at the time of such acquisition, there shall be no reduction of the payment or other obligations of Showa Denko under this Agreement as they pertain to products of Showa Denko’s OLED business, or of such third party under its similar license agreement as they pertain to products of the third party’s OLED business, unless expressly agreed to by Universal Display in writing.

2.10 Reservation of Rights. Except for the license rights expressly granted to Showa Denko under this Article 2, all rights to practice under the Universal Display Patents and to use the Universal Display Know-How are reserved unto Universal Display and its licensors. No implied rights or licenses to practice under any patents or to use any unpatented inventions, Know-How or technical information of either party are granted to the other party hereunder.

2.11 [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Article 3 Technical Assistance

3.1 Technical Assistance Agreement. Universal Display and Showa Denko shall conduct a program for Showa Denko to receive certain technical assistance relating to the Universal Display Technology under a separate Technical Assistance Agreement being entered into by the parties as of the same date hereof.

3.2 Export Control. Each party shall comply with all obligations imposed on it under applicable law to control access to technical data and materials under the U.S. Export Laws and Regulations, or any foreign counterparts thereof, and shall adhere to such laws and regulations in handling and disclosing any technical data and materials received by it under this Agreement.

3.3 Patent Matters, Attribution and Samples

Universal Display Corporation

Page 5 of 19

3.4 Patent Validity. Showa Denko shall not, and shall ensure that its Affiliates do not, challenge or oppose, or assist others in challenging or opposing (or initiating other proceedings of a similar nature), the issuance, validity or enforceability of any of the Universal Display Patents during the term of this Agreement, except that the foregoing shall not apply to patents in jurisdictions where such a prohibition is contrary to law or regulation.

3.5 Patent Marking. Upon Universal Display’s request, Showa Denko and its Permitted Sublicensees shall apply or cause to be applied to all Licensed Products, or their packaging, such reasonable markings or notices of the Universal Display Patents as may be requested in writing by Universal Display in order to reasonably protect Universal Display’s rights and interests therein under the laws of the countries in which such Licensed Products are or are likely to be marketed, sold or used.

3.6 Attribution. With respect to any Licensed Product that would, but for the license rights granted hereunder, infringe the [The confidential material contained herein has been omitted and has been separately filed with the Commission.] patents being sublicensed to Showa Denko, Showa Denko shall ensure, and require its Permitted Sublicensees to ensure, that such Licensed Products are marked on an exposed surface with one of the following notices: [The confidential material contained herein has been omitted and has been separately filed with the Commission.] When such a notice would not reasonably and customarily be applied to such a Licensed Product, it shall instead appear prominently i n data sheets or other literature accompanying the Licensed Product.

3.7 Non-Use of Certain Names. Showa Denko and its Permitted Sublicensees shall not use the names of Princeton, USC or Michigan in connection with any products, promotion or advertising without the prior consent of Princeton, USC or Michigan, as applicable, except to the extent reasonably required by law. Notwithstanding the foregoing sentence, Showa Denko and its Permitted Sublicensees may state that their license rights hereunder are derivative of rights granted by Princeton, USC and Michigan to Universal Display under the license agreement among them.

3.8 [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

3.9 Amendments to the Universal Display Patents. To the extent applicable law requires Universal Display to obtain Showa Denko’s approval for amendments to a specification of any Universal Display Patent licensed hereunder, Showa Denko agrees that it shall promptly approve all such reasonable amendments proposed by Universal Display.

Article 4 Consideration

4.1 License Fees. In partial consideration of the license rights granted by Universal Display hereunder, Showa Denko shall pay to Universal Display the license fees specified in Exhibit B hereto. Said license fees are due and payable on the date(s) specified in Exhibit B

Universal Display Corporation

Page 6 of 19

4.2 hereto. All such fees are non-refundable and shall be in addition to, and not applied to reduce, any royalties payable hereunder.

4.3 Royalties. In further consideration of the license rights granted by Universal Display hereunder, Showa Denko shall pay to Universal Display running royalties at the rates specified in Exhibit B hereto on account of Net Sales Revenue from Showa Denko’s or its Permitted Sublicensees’ worldwide sales or other disposition of Licensed Products. No multiple royalties shall be due because any Licensed Product, or its manufacture, sale, other disposition or usage, is or may be covered by more than one Universal Display Patent licensed to Showa Denko hereunder. For clarification, royalties shall not be cal culated or payable on account of any item that is supplied to Showa Denko by a Permitted Sublicensee or Authorized Contract Manufacturer, or to a Permitted Sublicensee by Showa Denko or an Authorized Contract Manufacturer, if such item does not include each and every element of an OLED Light Source, but rather royalties shall be calculated and payable on account of Showa Denko’s or the Permitted Sublicensee’s subsequent sale or other disposition of a Licensed Product that constitutes or incorporates the supplied item. [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

4.4 Royalty Reports. Within forty-five (45) days following the end of each [The confidential material contained herein has been omitted and has been separately filed with the Commission.] during the Term (and if the Term ends in the middle of a [The confidential material contained herein has been omitted and has been separately filed with the Commission.], within forty-five (45) days following the end of the Term), Showa Denko shall submit to Universal Display a written report, in English, that includes the following information (each, a “Royalty Report”): (a) a description of all Licensed Products sold or otherwise dispose d of by Showa Denko or Permitted Sublicensees during such [The confidential material contained herein has been omitted and has been separately filed with the Commission.], including the number of each type of Licensed Product sold; (b) gross amounts invoiced or received on account of such sales or other disposition of Licensed Products; and (c) Showa Denko’s reasonably detailed calculation of the royalties due and owing to Universal Display on account of such sales or other disposition of Licensed Products [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

4.5 Payment of Royalties. Within forty-five (45) days following the end of each [The confidential material contained herein has been omitted and has been separately filed with the Commission.] during the Term (and if the Term ends in the middle of a [The confidential material contained herein has been omitted and has been separately filed with the Commission.], within forty-five (45) days following the end of the Term), Showa Denko shall pay directly to Universal Display the royalties due and payable with respect to Licensed Products sold or otherwise disposed of during such [The confidential material contained herein has been omitted and has been separately filed with the Commission.].

4.6 [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Universal Display Corporation

Page 7 of 19

4.7 [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Article 5 Payment Terms; Audit Rights

5.1 Payments. All amounts due to Universal Display hereunder shall be paid in U.S. Dollars by wire transfer to a bank designated by Universal Display in writing, or by such other means as the parties may agree in writing. Universal Display’s current wire instructions are as follows:

[The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Each payment shall be fully earned when due and nonrefundable once made. All payments due hereunder shall be made without set-off, deduction or credit for any amount owed (or alleged to be owed) by Universal Display to Showa Denko or any of its Affiliates. Without limiting its other rights or remedies on account of any late payment, Universal Display may require Showa Denko to pay interest on any late payments at a per annum rate equal to [The confidential material contained herein has been omitted and has been separately filed with the Commission.].

5.2 Payment Authorization and Associated Charges. Showa Denko shall secure all authorizations required for payment of all amounts due to Universal Display hereunder and shall bear all transfer fees, taxes and other charges associated therewith. If Showa Denko believes that any income taxes imposed by any national, provincial or local government of relevant countries on amount payable to Universal Display hereunder will need to be withheld, Showa Denko shall provide Universal Display with prompt written notice thereof. Thereupon, the parties will cooperate in good faith and use their best efforts to promptly file for and obtain appropriate governmental exemptions that would elim inate the requirement for Showa Denko to withhold such taxes. If, notwithstanding these efforts, tax withholding is nonetheless required, Showa Denko may make the appropriate withholding from amounts payable to Universal Display hereunder, and Showa Denko shall then promptly pay the withheld amounts to the appropriate tax authorities. Promptly upon making each such tax payment, Showa Denko shall obtain and forward to Universal Display the official tax receipt(s) issued by the relevant government to support Universal Display’s claim to applicable tax credits or refunds.

5.3 Currency Conversion and Restriction. All royalties due hereunder based on Licensed Products sold or otherwise disposed of by Showa Denko or Permitted Sublicensees outside of the United States shall be payable in U.S. Dollars at the rate of exchange for the currency of the country in which such sales or usage occurs, which rate of exchange shall equal the exchange rate as published in The Wall Street Journal on the last business day of the [The confidential material contained herein has been omitted and has been separately filed with the Commission.] for which payment is being made. All royalties shall be paid to Universal Displa y without deduction of currency exchange fees or other similar amounts. If at any time the legal restrictions of a country outside of the United States prevent Showa Denko from paying Universal Display any amounts due hereunder, Universal Display may direct Showa Denko to make such payment to Universal Display’s account in a bank or other depository of such country.

Universal Display Corporation

Page 8 of 19

5.4 Records; Audit and Inspection. Showa Denko and its Permitted Sublicensees and Authorized Contract Manufacturers shall keep accurate and complete financial and technical records with respect to their manufacture and sale or other disposition of Licensed Products, and with respect to the royalties payable to Universal Display hereunder on account thereof, for a minimum of three (3) years from the date of payment of said royalties. An independent certified public accountant selected by Universal Display and approved by Showa Denko (such approval not to be unreasonably withheld), together with such technical support staff as such accountant reasonably deems necessary, shall have the right to audit such records and inspect such of Showa Denko’s or its Permitted Sublicensees’ or Authorized Contract Manufacturers’ materials, equipment and manufacturing processes as are reasonably necessary in order to verify Showa Denko’s payment of all royalties due hereunder. Universal Display shall give reasonable advance notice of any such audit or inspection to Showa Denko, and such audit or inspection shall be conducted during Showa Denko’s or the Permitted Sublicensee’s or Authorized Contract Manufacturer’s normal business hours and in a manner that does not cause unreasonable disruption to Showa Denko’s or the Permitted Sublicensee’s or Authorized Contract Manufacturer’s conduct of its business. The results of any such audit or inspection shall be deemed a Confidential Item (defined below) of Showa Denko and shall not be disclosed by Universal Display except as may be necessary for Universal Display to enforce its rights h ereunder. If the audit or inspection reveals that Showa Denko has underpaid any royalties due to Universal Display, Showa Denko shall immediately pay to Universal Display all unpaid royalties, plus interest on the unpaid amounts from the date payment was initially due at the rate specified in Section 6.1 above. Universal Display shall be responsible for paying the fees and expenses charged by the accountant for conducting any audit or inspection hereunder; provided, however, that if the unpaid royalties exceed [The confidential material contained herein has been omitted and has been separately filed with the Commission.] of the total royalties that should have been paid by Showa Denko during the audited period, Showa Denko shall promptly reimburse Universal Display for the reasonable fees and expenses charged by such accountant.

Article 6 Confidentiality and Publicity

6.1 Obligations of Confidentiality and Non-Use. Each party (the “Recipient”) shall handle and maintain all Confidential Items (defined below) of the other party in accordance with the following terms and conditions:

6.1.1 Recipient shall not publish, disclose or otherwise disseminate any Confidential Items of the other party, except to such of Recipient’s (and, in the case of Showa Denko, its Permitted Sublicensees’ and Authorized Contract Manufacturers’) employees, officers and agents who have a “need to know” it to accomplish the purposes of this Agreement, and then only if such persons previously have agreed in writing to handle and maintain such Confidential Items in accordance with the provisions of this Agreement or provisions substantially similar thereto. Disclosure or dissemination of Confidential Items of the other party to additional persons or entities requires the prior written approval of such other party, which consent shall not b e unreasonably withheld.

6.1.2 Recipient shall maintain all Confidential Items of the other party in a safe and secure place with reasonable safeguards to prevent any unauthorized access to or disclosure

Universal Display Corporation

Page 9 of 19

6.1.3 of such Confidential Items. As used herein, “reasonable safeguards” means all safeguards that a reasonable person would take to protect the Confidential Item in question, which safeguards shall be no less than the safeguards Recipient takes to protect its own confidential or proprietary items of a similar nature.

6.1.4 Recipient may copy Confidential Items of the other party only as is reasonably necessary for Recipient to accomplish the purposes of this Agreement. [The confidential material contained herein has been omitted and has been separately filed with the Commission.] copying or reproduction of Confidential Items that are chemical substances is strictly prohibited.

6.1.5 Recipient shall not utilize or exploit any Confidential Items of the other party, or permit or assist others to utilize or exploit such Confidential Items, except as is reasonably necessary to accomplish the purposes of this Agreement. Reverse engineering, disassembly or other methods designed to derive the composition, structure, method of manufacture or purity of any Confidential Items that are chemical substances is strictly prohibited [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

6.1.6 Recipient shall not publish or otherwise disclose to third parties any test results or other information or data regarding Recipient’s evaluation of any Confidential Items of the other party without the other party’s prior written consent.

6.1.7 Promptly upon learning of any unauthorized use or disclosure of any Confidential Item of the other party, Recipient shall provide the other party with written notice thereof and take such other steps as are reasonably requested by the other party in order to limit the effects of such use or disclosure and/or prevent any further unauthorized use or disclosure of such Confidential Item.

6.1.8 Promptly upon the expiration or sooner termination of this Agreement, Recipient shall return to the other party, destroy and/or delete from Recipient’s records and computer systems all Confidential Items of the other party, including any copies or portions thereof, in Recipient’s possession or control; provided, however, that Recipient may retain one copy of documents incorporating Confidential Items for archival purposes only. Within thirty (30) days following the other party’s written request, Recipient shall provide the other party with a certificate of Recipient’s compliance with the foregoing requirements.

6.2 Definition of Confidential Items. As used herein, “Confidential Items” of a party are all trade secret, proprietary and confidential information and materials, in written, oral, visual or electronic form, relating to such party’s or its licensors’, suppliers’ or business partners’ technologies, compounds, research programs, operations and/or financial or business condition (including, without limitation, know-how, data, drawings, designs, specifications, formulations, processes, methods, equipment, software and pricing information) that is (i) disclosed in writing and marked as “Confidential̶ 1;, “Proprietary” or with similar words at the time of disclosure, or (ii) orally or otherwise visually disclosed and identified as confidential or proprietary at the time of

Universal Display Corporation

Page 10 of 19

6.3 disclosure and confirmed as such in writing within thirty (30) days thereafter. Notwithstanding the foregoing, “Confidential Items” of a party shall not include any information or materials that:

6.3.1 are approved by such party in writing for release by Recipient without restriction;

6.3.2 Recipient can demonstrate by written records were previously known to Recipient other than through a prior disclosure by such party or any third party with an obligation of confidentiality to such party;

6.3.3 are publicly known as of the date of this Agreement, or become public knowledge subsequent thereto, through no act or omission of Recipient or any third party receiving such items from or through Recipient;

6.3.4 are obtained by Recipient in good faith from a third party without the violation of any obligation of confidentiality to such party by either Recipient or the third party; or

6.3.5 are independently developed by or on behalf of Recipient without the benefit of such party’s Confidential Items, as shown by competent written records.

6.4 [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

6.5 Disclosure Required by Law. This Agreement shall not restrict Recipient from disclosing any Confidential Items of the other party to the extent required by applicable law, or by the order of any court or government agency; provided, however, that Recipient shall afford the other party prompt notice of such law or order, so that the other party may interpose an objection to such disclosure or take whatever other actions the other party deems appropriate to protect such Confidential Items, and provided further that Recipient shall use all reasonable efforts to limit such disclosure to only those Confidential Items that are required to be disclosed and to ensure that the person or entity to whom su ch Confidential Items are disclosed agrees to keep them confidential.

6.6 Responsibility for Personnel. Recipient shall be responsible for the acts or omissions of any persons or entities receiving Confidential Items of the other party from or through Recipient to the extent such acts or omissions, if performed or not performed by Recipient, would constitute violations of this Agreement by Recipient.

6.7 Universal Display’s Licensors. Notwithstanding the foregoing, Universal Display shall have the right to provide an unredacted copy of this Agreement, along with copies of all Royalty Reports, to each of Princeton, USC, Michigan and Motorola; provided that in such case Universal Display shall cause such third-party licensors to have first agreed in writing to handle and maintain such items in accordance with the provisions of this Article 7, or provisions substantially similar thereto.

Universal Display Corporation

Page 11 of 19

6.8 Confidentiality of this Agreement. The terms of this Agreement shall be deemed Confidential Items of each party and treated as such by both parties. Notwithstanding the foregoing sentence, either party may disclose in its public filings such of the terms of this Agreement as are reasonably required for such party to comply with applicable securities laws and regulations, including, without limitation, by filing an appropriately redacted copy of this Agreement in connection therewith.

6.9 Press Releases and Other Public Disclosure. Within four (4) business days following the date on which this Agreement is executed, Universal Display will be required to file with the U.S. Securities and Exchange Commission a Current Report on Form 8-K that describes the material terms of this Agreement. Concurrent with Universal Display’s filing of such Current Report, the parties will issue a joint press release describing the general nature of their business relationship. Each party shall provide a suitable quote from one of its high-level officials for this press release. Any subsequent press release regarding this Agreement or the relationship between th e parties must be consented to by both parties; provided, however, that this shall not prohibit either party from making any disclosure of this Agreement or the terms hereof to the extent required by law or regulation.

6.10 [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Article 7 Representations and Warranties; Disclaimers and Limitations of Liability

7.1 Warranties by Both Parties. Each party represents and warrants to the other that such party has the right, power and authority to enter into this Agreement and to perform its obligations hereunder, and that such performance will not violate any other agreement or understanding by which such party is bound.

7.2 Further Warranty by Universal Display. Universal Display additionally represents and warrants to Showa Denko that Universal Display owns or has sufficient rights in the Universal Display Technology to grant the license rights granted to Showa Denko hereunder.

7.3 Further Warranty by Showa Denko. Showa Denko additionally represents and warrants to Universal Display that it shall not, and that it shall ensure its Permitted Sublicensees do not, bind or purport to bind Universal Display to any affirmation, representation or warranty provided to any other person with respect to any Licensed Products it may manufacture, sell, offer for sale or use, or any processes it may employ in connection therewith.

7.4 Disclaimer of Additional Warranties. ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF NON-INFRINGEMENT, VALIDITY, QUALITY, PERFORMANCE, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, ARE HEREBY DISCLAIMED. In particular, Universal Display makes no representation or warranty that Showa Denko or any Permitted Sublicensee will be able to manufacture, sell or use any Licensed Products without obtaining additional license rights from third parties, and Showa Denko and its Permitted Sublicensees

Universal Display Corporation

Page 12 of 19

7.5 shall be solely responsible for determining the rights they are required to obtain and for obtaining all such rights.

7.6 Required Disclaimer of Princeton, USC and Michigan. PRINCETON, USC AND MICHIGAN MAKE NO REPRESENTATIONS AND WARRANTIES AS TO THE PATENTABILITY AND/OR DISCOVERIES INVOLVED IN ANY OF THE UNIVERSAL DISPLAY PATENTS LICENSED HEREUNDER. PRINCETON, USC AND MICHIGAN MAKE NO REPRESENTATION AS TO PATENTS NOW HELD OR WHICH WILL BE HELD BY OTHERS IN ANY FIELD AND/OR FOR ANY PARTICULAR PURPOSE. PRINCETON, USC AND MICHIGAN MAKE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.

7.7 Limitation on Certain Damages. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER, OR TO ANY THIRD PARTY CLAIMING THROUGH THE OTHER, WHETHER AS A RESULT OF BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES ARISING UNDER OR IN CONNECTION WITH A BREACH OR ALLEGED BREACH OF THIS AGREEMENT. The foregoing limitation shall not limit either party’s liability for: (a) any claims of bodily injury or damage to tangible property resulting from gross negligence or willful misconduct of such party or its Affiliates; (b) any knowing or willful unauthorized use of materials or technology of the other party or its Affiliates; (c) any knowing or willful infringement of patents of the other party or its Affiliates; or (d) any breach of the provisions of Article 7 respecting Confidential Items of the other party.

7.8 Essential Part of the Bargain. The parties acknowledge that the disclaimers and limitations of liability set forth in this Article 8 reflect a deliberate and bargained for allocation of risks between them and are intended to be independent of any exclusive remedies available under this Agreement, including any failure of such a remedy to achieve its essential purpose.

Article 8 Term and Termination

8.1 Term. The term of this Agreement (the “Term”) shall commence on the Effective Date and shall continue, unless terminated sooner as permitted hereunder, until the latter of the date of expiration of the last to expire of the Universal Display Patents. Unless otherwise expressly agreed in writing by the parties, all licenses granted under this Agreement shall expire immediately upon any termination of this Agreement.

8.2 Termination for Breach. Either party may terminate this Agreement on written notice to the other party if the other party materially breaches any of its obligations under this Agreement and fails to cure such breach within sixty (60) days following written notice thereof by the terminating party.

8.3 Termination for Challenge of Patents. Universal Display may terminate this Agreement on written notice to Showa Denko if Showa Denko or any of its Affiliates asserts or assists another in asserting (including through the use of a “dummy” person or entity), before any

Universal Display Corporation

Page 13 of 19

8.4 court, patent office or other governmental agency, that any of the Universal Display Patents are invalid or unenforceable, should be cancelled or invalidated (in whole or in part), or should otherwise not be granted, allowed or issued.

8.5 Other Termination. Either party may terminate this Agreement on written notice to the other party if the other party permanently ceases conducting business in the normal course, becomes insolvent or is adjudicated bankrupt, makes a general assignment for the benefit of its creditors, admits in writing its inability to pay its debts as they become due, permits the appointment of a receiver for its business or assets, or initiates or becomes the subject of any bankruptcy or insolvency proceedings which proceedings, if initiated involuntarily, are not dismissed with sixty (60) days thereafter.

8.6 Survival. The following provisions of this Agreement shall survive the expiration or earlier termination of this Agreement: (a) Articles 4 and 6 through 10; provided, however, that the obligations of each party with respect to Confidential Items of the other party disclosed hereunder shall survive the expiration or sooner termination of this Agreement for a period of five (5) years; (b) any payment or reporting obligations of Showa Denko respecting the sale or other disposition of Licensed Products occurring prior to the date of such expiration or earlier termination; and (c) any other provisions necessary to interpret the respective rights and obligations of the parties hereunder. 60; Any termination of this Agreement shall be in addition to, and not in lieu of, any other remedies that may be available, at law or equity, including an action for the recovery of damages.

Article 9 Miscellaneous

9.1 Independent Contractors. This Agreement is not intended by the parties to constitute, create, give effect to, or otherwise recognize a joint venture, partnership, or formal business organization of any kind. Each party hereto shall act as an independent contractor, and neither shall act as an agent of the other for any purpose. Neither party has the authority to assume or create any obligation, express or implied, on behalf of the other.

9.2 Force Majeure. Neither party shall be in breach of this Agreement for any failure of performance (other than a failure to pay amounts due and owing hereunder) caused by an event beyond its reasonable control and not due to its or its Affiliates’ fault or negligence. In the event that such a force majeure event occurs, the party unable to perform shall promptly notify the other party of such non-performance and its expected duration. In addition, such party shall in good faith maintain such partial performance of this Agreement as is reasonably possible, shall use all reasonable efforts to overcome the cause of nonperformance and shall resume full performance as soon a s is reasonably possible.

9.3 Notices. Any notices pertaining to the administration of this Agreement or any breach or alleged breach thereof shall be in writing and shall be deemed effectively given upon receipt of such notices by the recipient. Such notices shall be given by personal delivery, certified mail with postage prepaid and return receipt requested, or prepaid delivery using a recognized private courier, to each party at its address set forth below; provided, however, that the parties may agree to exchange technical data and information by email or facsimile

Universal Display Corporation

Page 14 of 19

9.4 correspondence in lieu of the methods described above. Either party may change its address for such notices at any time by means of a notice given in the manner provided in this paragraph.

All Royalty Reports and any other financial notices, to:

Universal Display Corporation		Showa Denko K.K.
375 Phillips Boulevard		13-9, Shiba Daimon 1-chome, Minato-ku
Ewing, New Jersey 08618		Tokyo, 105-8518 Japan

[The confidential material contained herein has been omitted and has been separately filed with the Commission.]

All other notices and communications:

[same as above]

[The confidential material contained herein has been omitted and has been separately filed with the Commission.]

9.5 Assignment. Neither party may assign or transfer any of its rights or delegate any of its obligations hereunder, by application of law or otherwise, without the prior written consent of the other party. Notwithstanding the foregoing sentence and subject to Section 2.7 above, either party may assign or transfer this Agreement, in its entirety and on written notice to the other party, to a successor in interest to all or substantially all of such party’s business or assets to which this Agreement relates. Any attempted assignment, transfer or delegation in violation of this paragraph shall be null and void and without force and effect. Nothing herein shall co nfer any rights upon any person other than the parties hereto and their respective permitted successors and assigns.

9.6 Equitable Relief. In the event of a party’s actual or reasonably anticipated infringement of the other party’s patents, unauthorized use of the other party’s proprietary materials or information; or breach of the provisions of Article 7 respecting the other party’s Confidential Items, the other party may seek to obtain such injunctions, order and decrees as may be necessary to restrain the activity, without the necessity of proving actual damages and without posting any bond or other security. Such injunctive relief shall be in addition to any other rights or remedies available to the other party under this Agreement, at law or in equity.

9.7 Choice of Law. This Agreement shall be governed by and construed in accordance with, the laws of the State of New York, U.S.A., without respect to its rules on the conflict of laws. The United Nations Convention on Contracts for the International Sale of Goods shall not apply. Any law or regulation providing that the language of a contract shall be construed against the drafter shall also not apply.

9.8 Dispute Resolution. [The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Universal Display Corporation

Page 15 of 19

9.9 Severability. In the event that any term of this Agreement is held to be invalid, illegal, or unenforceable, such invalidity, illegality, or unenforceability shall not affect any other portion of this Agreement, and there shall be deemed substituted for such term other term(s) that are permitted by applicable law and that will most fully realize the intent of the parties as expressed in this Agreement.

9.10 No Waivers. The failure of either party to enforce, or any delay in enforcing, any right, power or remedy that such party may have under this Agreement shall not constitute a waiver of any such right, power or remedy, or release the other party from any obligations under this Agreement, except by a written document signed by the party against whom such waiver or release is sought to be enforced.

9.11 Entire Agreement; Amendments. This Agreement constitutes the entire understanding and agreement of the parties respecting the subject matter hereof and supersedes any and all prior agreements, arrangements or understandings between the parties, whether written or oral, relating thereto. This Agreement may not be amended or supplemented in any way except by a written document signed by both parties.

9.12 Counterparts. This Agreement may be executed by the parties hereto in separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

9.13 Headings. The headings used in this Agreement are for reference only and are not to be used in the interpretation or construction of this Agreement.

IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized representatives.

Showa Denko K.K.		Universal Display Corporation


By:	/s/ K. Tsukamoto	By:	/s/ Steven V. Abramson

Name:	Kenji Tsukamoto	Name:	Steven V. Abramson

Title:	Director, Chief Technology Officer	Title:	President

Date:	Dec. 15, 2009	Date:	Dec. 17, 2009

Universal Display Corporation

Page 16 of 19

Exhibit A

OLED Light Source

[The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Universal Display Corporation

Page 17 of 19

Exhibit B

License Fees and Royalty Rates

License Fees:

[The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Royalty Rates:

[The confidential material contained herein has been omitted and has been separately filed with the Commission.]

Universal Display Corporation

Page 18 of 19

Exhibit C

Universal Display Patents and Patent Publications

Separately attached hereto.

Universal Display Corporation

Page 19 of 19

Pennsylvania		23-2372688
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

375 Phillips Boulevard, Ewing, New Jersey		08618
(Address of principal executive offices)		(Zip Code)

Title of Each Class	Name of Each Exchange on Which Registered
Common Stock, $0.01 par value	The NASDAQ Stock Market LLC

ITEM 1.	BUSINESS……………………………………………...…………………………………..............…...…..	2
ITEM 1A.	RISK FACTORS…………………………...………………..…………...………………………………….	14
ITEM 1B.	UNRESOLVED STAFF COMMENTS…………...……..……………………………...……..…................	22
ITEM 2.	PROPERTIES………………….………………………………………...…………………………………	22
ITEM 3.	LEGAL PROCEEDINGS….……………………………………………………..………………………...	23
ITEM 4.	REMOVED AND RESERVED….……………………………………………………..…………………	25

ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES…………………………………………………	25
ITEM 6.	SELECTED FINANCIAL DATA………...…………………………………………………………..........	28
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS…………...……………………………………………………………………………..	28
ITEM 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK…………………...	35
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA…........………………………………..	35
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE………………………………………………………………………..............	35
ITEM 9A.	CONTROLS AND PROCEDURES……………….……………………………………………………….	35
ITEM 9B.	OTHER INFORMATION……………….…………………………………………………………………..	36

ITEM 10.	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE………………………...	36
ITEM 11.	EXECUTIVE COMPENSATION………...………………………………………………………..............	36
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS……..………………………….................................................	36
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE………………………………………………………………………………………….	36
ITEM 14.	PRINCIPAL ACCOUNTING FEES AND SERVICES………….……………….....................................	36

Name	Age	Position
Sherwin I. Seligsohn	74	Founder and Chairman of the Board of Directors
Steven V. Abramson	58	President, Chief Executive Officer and Director
Sidney D. Rosenblatt	62	Executive Vice President, Chief Financial Officer, Treasurer, Secretary and Director
Julia J. Brown	49	Vice President and Chief Technical Officer
Janice K. Mahon	52	Vice President of Technology Commercialization and General Manager of Material Supply Business
Michael G. Hack	53	Vice President of Strategic Product Development and General Manager of OLED Lighting and Custom Displays Business

	High Close		Low Close
2009
Fourth Quarter…………………………………….	$	13.72	$	10.68
Third Quarter……………………………………….		12.78		9.18
Second Quarter……………………………………..		11.98		8.10
First Quarter………………………………………..		10.12		5.04
2008
Fourth Quarter…………………………………….	$	11.75	$	5.51
Third Quarter……………………………………….		16.08		10.96
Second Quarter……………………………………..		15.95		12.32
First Quarter………………………………………..		20.78		13.43

Period	Total Number of Shares Purchased		Weighted Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Program		Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
October 1 – October 31		401	$	13.59		n/a		--
November 1 – November 30		--		--		n/a		--
December 1 – December 31		--		--		n/a		--
Total		401	$	13.59		n/a		--

	Cumulative Total Return
		12/04	12/05	12/06	12/07	12/08	12/09
Universal Display Corp.		100.00	116.78	166.78	229.67	105.00	137.33
Russell 2000		100.00	104.55	123.76	121.82	80.66	102.58
NASDAQ Electronic Components		100.00	107.81	101.44	116.92	59.73	97.30

	Year Ended December 31,
	2009			2008			2007			2006			2005
Operating Results:
Total revenue……………..….	$	15,786,617		$	11,075,224		$	11,305,907		$	11,921,292		$	10,147,995
Research and development expense….		20,015,080			18,908,783			18,360,509			17,150,673			16,468,291
Selling, general and administrative expense…		10,921,859			10,170,593			9,569,381			8,902,462			7,704,931
Interest income………..		669,633			2,607,897			3,599,229			2,168,933			1,419,858
Income tax benefit……….		129,915			962,478			804,980			544,567			424,207
Net loss…………….		(20,505,320	)		(19,139,736	)		(15,975,841	)		(15,186,804	)		(15,801,612	)
Net loss attributable to common shareholders………		(20,505,320	)		(19,139,736	)		(15,975,841	)		(15,186,804	)		(15,801,612	)
Net loss per share, basic and diluted….		(0.56	)		(0.53	)		(0.47	)		(0.49	)		(0.56	)
Balance Sheet Data:
Total assets…….	$	80,139,887		$	96,228,505		$	105,000,071		$	72,331,536		$	73,819,417
Current liabilities……		13,965,959			15,769,505			12,790,531			14,382,673			11,974,854
Long-tem debt………….		—			—			—			—			—
Shareholders’ equity……..		59,627,526			76,714,463			89,215,957			54,382,363			57,616,463
Other Financial Data:
Working capital………	$	53,663,617		$	64,600,256		$	73,979,638		$	37,422,740		$	38,347,913
Capital expenditures…………		258,761			1,277,098			1,225,857			2,349,033			5,656,905
Weighted average shares used in computing basic and diluted net loss per common share……		36,479,331			35,932,372			33,759,581			30,855,297			28,462,925
Shares of common stock outstanding, end of period...		36,818,440			36,131,981			35,563,201			31,385,408			29,545,471

	Payments due by period
Contractual Obligations	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Sponsored research obligation	$	6,806,848	$	2,331,275	$	4,475,573	$	—	$	—
Minimum royalty obligation (1)		500,000		100,000		200,000		200,000	100,000/year(1)

Total (2)	$	7,306,848	$	2,431,275	$	4,675,573	$	200,000	$100,000/year(1)

Management’s Report on Internal Control Over Financial Reporting………………...	F-2
Reports of Independent Registered Public Accounting Firm…………………………..	F-3
Consolidated Balance Sheets…………………………………..………………..…….	F-5
Consolidated Statements of Operations…………………………………..…………...	F-6
Consolidated Statements of Shareholders’ Equity and Comprehensive Loss…………	F-7
Consolidated Statements of Cash Flows…………………………………..…………..	F-9
Notes to Consolidated Financial Statements…………………………………..………	F-10

	+	Confidential treatment has been accorded to certain portions of this exhibit pursuant to Rule 406 under the Securities Act of 1933, as amended, or Rule 24b-2 under the Securities Exchange Act of 1934, as amended.
	++	Confidential treatment has been requested as to certain portions of this exhibit pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended.

	By:/s/ Sidney D. Rosenblatt
	Sidney D. Rosenblatt
	Executive Vice President, Chief Financial Officer,
	Treasurer and Secretary

	Date: March 15, 2010

Name	Title	Date
/s/ Sherwin I. Seligsohn Sherwin I. Seligsohn	Founder and Chairman of the Board of Directors	March 15, 2010
/s/ Steven V. Abramson Steven V. Abramson	President, Chief Executive Officer and Director (principal executive officer)	March 15, 2010
/s/ Sidney D. Rosenblatt Sidney D. Rosenblatt	Executive Vice President, Chief Financial Officer, Treasurer, Secretary and Director (principal financial and accounting officer)	March 15, 2010
/s/ Leonard Becker Leonard Becker	Director	March 15, 2010
/s/ Elizabeth H. Gemmill Elizabeth H. Gemmill	Director	March 15, 2010
/s/ C. Keith Hartley C. Keith Hartley	Director	March 15, 2010
/s/ Lawrence Lacerte Lawrence Lacerte	Director	March 15, 2010


Consolidated Financial Statements:
Management’s Report on Internal Control Over Financial Reporting	F-2
Reports of Independent Registered Public Accounting Firm	F-3
Consolidated Balance Sheets	F-5
Consolidated Statements of Operations	F-6
Consolidated Statements of Shareholders’ Equity and Comprehensive Loss	F-7
Consolidated Statements of Cash Flows	F-9
Notes to Consolidated Financial Statements	F-10

	December 31,
	2009			2008

ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	22,701,126		$	28,321,581
Short-term investments		41,172,955			49,132,619
Accounts receivable		3,344,255			2,450,444
Inventory		641			2,209
Other current assets		410,599			462,908

Total current assets		67,629,576			80,369,761
PROPERTY AND EQUIPMENT, net		11,048,763			12,859,628
ACQUIRED TECHNOLOGY, net		1,234,272			2,929,344
OTHER ASSETS		227,276			69,772

TOTAL ASSETS	$	80,139,887		$	96,228,505


LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	1,275,695		$	1,585,015
Accrued expenses		5,238,870			5,296,433
Deferred license fees		6,047,467			6,148,267
Deferred revenue		1,403,927			2,739,790

Total current liabilities		13,965,959			15,769,505
DEFERRED LICENSE FEES		2,826,237			3,407,037
DEFERRED REVENUE		—			337,500
STOCK WARRANT LIABILITY		3,720,165			—

Total liabilities		20,512,361			19,514,042

COMMITMENTS AND CONTINGENCIES (Note 11)

SHAREHOLDERS’ EQUITY:
Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000 shares of Series A Nonconvertible Preferred Stock issued and outstanding (liquidation value of $7.50 per share or $1,500,000)		2,000			2,000
Common Stock, par value $0.01 per share, 50,000,000 shares authorized, 36,818,440 and 36,131,981 shares issued and outstanding at December 31, 2009 and 2008, respectively		368,184			361,320
Additional paid-in capital		256,340,530			256,696,849
Unrealized gain on available-for-sale securities		25,517			126,497
Accumulated deficit		(197,108,705	)		(180,472,203	)

Total shareholders’ equity		59,627,526			76,714,463

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	80,139,887		$	96,228,505

	Series A
	Nonconvertible								Additional
	Preferred Stock				Common Stock				Paid-in
	Shares		Amount		Shares		Amount		Capital

BALANCE, JANUARY 1, 2007		200,000	$	2,000		31,385,408	$	313,854	$	199,505,981
Issuance of common stock through a public offering, net of expenses of $2,599,977		—		—		2,800,000		28,000		37,972,023
Exercise of common stock options and warrants		—		—		1,169,648		11,696		8,528,247
Stock-based employee compensation, net of shares withheld for employee taxes		—		—		70,238		703		2,049,554
Stock-based non-employee compensation		—		—		—		—		23,336
Issuance of common stock to Board of Directors and Scientific Advisory Board		—		—		37,796		378		714,364
Issuance of common stock in connection with materials and license agreements		—		—		100,111		1,001		1,447,489
Net loss		—		—		—		—		—
Unrealized gain on available-for-sale securities		—		—		—		—		—

Comprehensive loss

BALANCE, DECEMBER 31, 2007		200,000		2,000		35,563,201		355,632		250,240,994

Exercise of common stock options and warrants		—		—		352,864		3,529		2,403,631
Stock-based employee compensation, net of shares withheld for employee taxes		—		—		86,340		863		2,085,315
Stock-based non-employee compensation		—		—		174		2		6,099
Issuance of common stock to Board of Directors and Scientific Advisory Board		—		—		42,932		429		744,558
Issuance of common stock in connection with materials and license agreements		—		—		86,470		865		1,216,252
Net loss		—		—		—		—		—
Unrealized gain on available-for-sale securities		—		—		—		—		—

Comprehensive loss

BALANCE, DECEMBER 31, 2008		200,000		2,000		36,131,981		361,320		256,696,849

Cumulative effect of the adoption of revisions to ASC 815, See Note 2		—		—		—		—		(6,557,928	)
Exercise of common stock options and warrants		—		—		340,279		3,403		1,698,735
Stock-based employee compensation, net of shares withheld for employee taxes		—		—		147,078		1,471		2,446,034
Stock-based non-employee compensation		—		—		450		4		7,007
Issuance of common stock to Board of Directors and Scientific Advisory Board		—		—		61,742		617		750,298
Issuance of common stock in connection with materials and license agreements		—		—		122,854		1,228		1,169,492
Issuance of common stock to employees under an Employee Stock Purchase Plan		—		—		14,056		141		130,043
Net loss		—		—		—		—		—
Unrealized loss on available-for-sale securities		—		—		—		—		—

Comprehensive loss

BALANCE, DECEMBER 31, 2009		200,000	$	2,000		36,818,440	$	368,184	$	256,340,530

	Unrealized Gain (Loss) on						Total
	Available-for-Sale			Accumulated			Shareholders’
	Securities			Deficit			Equity

BALANCE, JANUARY 1, 2007	$	(82,846	)	$	(145,356,626	)	$	54,382,363
Issuance of common stock through a public offering, net of expenses of $2,599,977		—			—			38,000,023
Exercise of common stock options and warrants		—			—			8,539,943
Stock-based employee compensation, net of shares withheld for employee taxes		—			—			2,050,257
Stock-based non-employee compensation		—			—			23,336
Issuance of common stock to Board of Directors and Scientific Advisory Board		—			—			714,742
Issuance of common stock in connection with materials and license agreements		—			—			1,448,490
Net loss		—			(15,975,841	)		(15,975,841	)
Unrealized gain on available-for-sale securities		32,644			—			32,644

Comprehensive loss								(15,943,197	)

BALANCE, DECEMBER 31, 2007		(50,202	)		(161,332,467	)		89,215,957

Exercise of common stock options and warrants		—			—			2,407,160
Stock-based employee compensation, net of shares withheld for employee taxes		—			—			2,086,178
Stock-based non-employee compensation		—			—			6,101
Issuance of common stock to Board of Directors and Scientific Advisory Board		—			—			744,987
Issuance of common stock in connection with materials and license agreements		—			—			1,217,117
Net loss		—			(19,139,736	)		(19,139,736	)
Unrealized gain on available-for-sale securities		176,699			—			176,699

Comprehensive loss								(18,963,037	)

BALANCE, DECEMBER 31, 2008		126,497			(180,472,203	)		76,714,463

Cumulative effect of the adoption of revisions to ASC 815, See Note 2		—			3,868,818			(2,689,110	)
Exercise of common stock options and warrants		—			—			1,702,138
Stock-based employee compensation, net of shares withheld for employee taxes		—			—			2,447,505
Stock-based non-employee compensation		—			—			7,011
Issuance of common stock to Board of Directors and Scientific Advisory Board		—			—			750,915
Issuance of common stock in connection with materials and license agreements		—			—			1,170,720
Issuance of common stock to employees under an Employee Stock Purchase Plan		—			—			130,184
Net loss		—			(20,505,320	)		(20,505,320	)
Unrealized loss on available-for-sale securities		(100,980	)		—			(100,980	)

Comprehensive loss								(20,606,300	)

BALANCE, DECEMBER 31, 2009	$	25,517		$	(197,108,705	)	$	59,627,526

	Amortized		Unrealized					Aggregate Fair
Investment Classification	Cost		Gains		(Losses)			Market Value

December 31, 2009-
Certificates of deposit	$	8,688,457	$	1,633	$	(7,245	)	$	8,682,845
U.S. Government bonds		32,458,981		31,140		(11	)		32,490,110

	$	41,147,438	$	32,773	$	(7,256	)	$	41,172,955

December 31, 2008-
Certificates of deposit	$	10,318,000	$	35,577	$	(3,323	)	$	10,350,254
U.S. Government bonds		38,688,122		96,121		(1,878	)		38,782,365

	$	49,006,122	$	131,698	$	(5,201	)	$	49,132,619

			Fair Value Measurements, Using
	Total carrying value as of December 31, 2009		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Investments	$	41,172,955	$	41,172,955	$	—	$	—
Stock warrant liability		3,720,165		—		—		3,720,165

	Year ended December 31, 2009

Fair value of stock warrant liability, beginning of year	$	—
Cumulative effect of reclassification of stock warrant liability under ASC 815, see “Recent Accounting Pronouncements” below		2,689,110
Unrealized loss for period		1,031,055

Fair value of stock warrant liability, end of year	$	3,720,165

Contractual life (years)		0.13-1.64
Expected volatility		40.51-76.72%
Risk-free interest rate		0.05-0.81%
Annual dividend yield		—

				Weighted
				Average
				Exercise
	Options			Price

Outstanding at January 1, 2009		2,966,116		$	10.10
Granted		500			10.04
Exercised		(318,365	)		4.91
Forfeited		—
Cancelled		(51,750	)		14.61

Outstanding at December 31, 2009		2,596,501			10.65
Vested and expected to vest		2,596,230			10.65
Exercisable at December 31, 2009		2,587,501			10.63

				Weighted
				Average
				Grant Date
	Options			Fair Value

Unvested options at January 1, 2009		28,000		$	9.69
Granted		500			8.06
Vested		(19,500	)		9.11
Forfeited		—			—

Unvested options at December 31, 2009		9,000		$	10.87

		Outstanding								Exercisable
		Number of		Weighted-						Number of		Weighted-
		Options		Average		Weighted-				Options		Average		Weighted-
		Outstanding		Remaining		Average		Aggregate		Outstanding		Remaining		Average		Aggregate
		at December 31,		Contractual		Exercise		Intrinsic		at December, 31		Contractual		Exercise		Intrinsic
Exercise Price		2009		Life (Years)		Price		Value (A)		2009		Life (Years)		Price		Value (A)

$	5.45–8.14		683,265		4.00	$	7.04	$	3,637,967		683,265		4.00	$	7.04	$	3,637,967
	8.15-9.50		546,000		1.68		8.88		1,897,688		546,000		1.68		8.88		1,897,688
	9.51–10.51		707,528		4.47		10.35		1,423,897		707,528		4.47		10.35		1,423,897
	10.52–18.13		537,208		4.09		15.00		45,585		528,208		4.06		15.01		45,585
	18.14–24.38		122,500		1.02		21.26		—		122,500		1.02		21.26		—

$	5.45–24.38		2,596,501		3.52	$	10.65	$	7,005,137		2,587,501		3.51		10.63	$	7,005,137

	Related Tax		Deferred Tax		Expiration
	Deduction		Asset		Date

Loss carry forwards:
Federal net operating loss	$	168,736,000	$	57,370,000	2011 to 2029
State net operating loss		124,060,000		7,353,000	2011 to 2029

Total loss carry forwards	$	292,796,000	$	64,723,000

Tax credit carry forwards:
Research tax credit		n/a	$	5,151,000	2018 to 2029
State tax credits		n/a		1,641,000	2014 to 2024

Total credit carry forwards		n/a	$	6,792,000

	Three Months Ended
	March 31			June 30			September 30			December 31			Total

Revenue	$	2,833,858		$	2,956,354		$	5,145,393		$	4,851,012		$	15,786,617
Net loss		(5,569,599	)		(6,415,178	)		(4,672,847	)		(3,847,696	)		(20,505,320	)
Basic and diluted net loss per common share		(0.15	)		(0.18	)		(0.13	)		(0.10	)		(0.56	)

Agreed and Accepted by Employee:

/s/ Michael Hack		2/5/07
(Signature of Employee)		Date

Michael Hack
(Employee’s Name)



(Employee’s Address)

Acknowledgment of receipt and acceptance by:	UNIVERSAL DISPLAY CORPORATION

	By:	/s/ Sidney D. Rosenblatt

	Name:	Sidney D. Rosenblatt

	Title:	CFO

	Date:	2/1/07